Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Moelis & Co
MC
$5.21B
| $75.8M | 0.01% |
1,106,178
+1,001,915
| +961% | +$64.7M |
|
902
PUT
Southern Company
SO
$107B
| $75.7M | 0.01% |
839,200
+389,900
| +87% | +$33.3M |
|
903
Veralto
VLTO
$23.8B
| $75.2M | 0.01% |
672,298
-206,525
| -24% | -$21.8M |
|
904
Affiliated Managers Group
AMG
$9.7B
| $75.2M | 0.01% |
422,698
-31,115
| -7% | -$5.29M |
|
905
PUT
Tractor Supply
TSCO
$18.8B
| $75.1M | 0.01% |
1,290,000
-94,500
| -7% | -$5.08M |
|
906
CALL
Okta
OKTA
$26.9B
| $75M | 0.01% |
1,008,800
+86,300
| +9% | +$7.54M |
|
907
PUT
Prudential Financial
PRU
$43B
| $75M | 0.01% |
619,000
-174,700
| -22% | -$20.7M |
|
908
Encompass Health
EHC
$12.2B
| $74.9M | 0.01% |
775,255
-761,162
| -50% | -$68.4M |
|
909
BridgeBio Pharma
BBIO
$15.9B
| $74.9M | 0.01% |
2,942,114
+785,665
| +36% | +$20.6M |
|
910
PUT
NXP Semiconductors
NXPI
$58.5B
| $74.8M | 0.01% |
311,500
+164,700
| +112% | +$41.3M |
|
911
Eastman Chemical
EMN
$8.43B
| $74.3M | 0.01% |
663,884
-72,027
| -10% | -$7.2M |
|
912
Alexandria Real Estate Equities
ARE
$8.33B
| $74.3M | 0.01% |
625,539
+589,914
| +1,656% | +$70.3M |
|
913
PUT
Comcast
CMCSA
$92.9B
| $74.2M | 0.01% |
1,775,600
-927,500
| -34% | -$36.6M |
|
914
PUT
Capri Holdings
CPRI
$1.77B
| $74M | 0.01% |
1,744,200
+1,386,200
| +387% | +$48.6M |
|
|
WCC
915
CALL
WESCO International
WCC
$17.5B
| $74M | 0.01% |
440,500
+286,500
| +186% | +$46.5M |
|
916
Amneal Pharmaceuticals
AMRX
$6.02B
| $74M | 0.01% |
8,892,293
-1,096,432
| -11% | -$8.57M |
|
917
CALL
Clorox
CLX
$12.9B
| $74M | 0.01% |
454,000
-32,600
| -7% | -$4.83M |
|
918
PUT
Hershey
HSY
$37.4B
| $73.9M | 0.01% |
385,300
-79,700
| -17% | -$15.5M |
|
919
Regeneron Pharmaceuticals
REGN
$83B
| $73.9M | 0.01% |
70,260
-39,296
| -36% | -$43.7M |
|
920
CALL
Caesars Entertainment
CZR
$6.04B
| $73.9M | 0.01% |
1,769,300
+319,900
| +22% | +$12M |
|
921
VeriSign
VRSN
$26B
| $73.8M | 0.01% |
388,702
+271,744
| +232% | +$49M |
|
922
CALL
iShares US Real Estate ETF
IYR
$4.58B
| $73.8M | 0.01% |
724,300
-763,000
| -51% | -$73.5M |
|
|
MRSH
923
Marsh
MRSH
$90B
| $73.6M | 0.01% |
330,061
+173,474
| +111% | +$38.5M |
|
924
PUT
Duke Energy
DUK
$97.1B
| $73.2M | 0.01% |
634,700
+231,300
| +57% | +$25.7M |
|
|
925
iShares US Real Estate ETF
IYR
$4.58B
| $72.9M | 0.01% |
716,036
+610,484
| +578% | +$58.8M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,611 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.